Erasca
Price & Volume
Stats
See more52W Range | $1.21-$24.28 |
Market Cap | $3.8B |
Shares Short | 31M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.93 |
News
See moreYahoo Finance • 10 days ago
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 10 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
Yahoo Finance • 12 days ago
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
Yahoo Finance • 12 days ago
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
About
CEO | Dr. Jonathan E. Lim M.D. |
CFO | Dr. David M. Chacko M.D. |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |